InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Cote Jennifer. Director active across 1 company, notably Harvard Bioscience INC. Aggregated, 6 filings have been published. History available since 6 March 2023. The latest transaction was filed on 19 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Jennifer Cote has 6 filings in total, all on Harvard Bioscience INC, where she is Chief Financial Officer. Across the 6 sampled filings, the period runs from 2023-03-08 to 2025-03-21, with the most frequent transaction nature being tax withholding, and buy and sell amounts of EUR 0 each.